Pic courtesy The Indian Express
New Delhi: The Pune-based Serum Institute of India (SII) will start manufacturing the anti-COVID vaccine Sputnik V from September, Russian authorities said on Tuesday.
The RDIF (Russian Direct Investment Fund) said they “intend to produce over 300 million doses in India per year” and technology transfer has already started.
“SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India), the cultivation process has begun,” read a statement from RDIF.
The announcement came as India is trying to ramp up its vaccination efforts. The target is to inoculate all the adult population by December.
On his part, SII chief Adar Poonawalla expressed happiness on the partnership with RDIF to manufacture the Sputnik vaccine. “We hope to make millions of doses in the coming months with trial batches starting in the month of September,” Poonawalla was quoted as saying by NDTV.
Bhubaneswar: Vedanta Aluminium has expanded its ‘Swarna Prashan’ initiative, an Ayurveda-based immunisation drive, to over…
Ottawa: The government in Canada, led by Justin Trudeau, on Friday denied linking Prime Minister…
Bhubaneswar: A woman died while her younger sister is battling for life after an alleged…
Madurai: Founder of KIIT, KISS, and KIMS, Achyuta Samanta has been honoured with Lifetime Achievement…
Koraput: Three persons died while one was seriously injured after a truck rammed into a…
New Delhi: The BJP-led NDA government will introduce 15 bills, including one to amend the…
Bhubaneswar: A newborn baby, who was allegedly sold by her parents in Odisha's Balangir district,…
Mumbai: Exit polls have given Bharatiya Janata Party-led Mahayuti alliance an edge in the neck-to-neck…